SCLX

Scilex Holding Co. (SCLX) | Rumor.io

Scilex Holding

SCLX

Attention (50-day avg)0%

Attention rank (50-day avg)#2,296

Bullish sentiment (50-day avg)77%

Price to earnings ratio-0.12

Market capitalization31.6M

Earnings per share-49.7

Dividend yield (TTM)—

Revenue (annual)30.3M

Net income (annual)-374.1M

Social

What share of all stock conversation is about SCLX?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% +0	0% +0	0% 0

Jul 8

Scilex Holding Company ($SCLX) is involved in a joint venture that will send 500k shares to Quantum Scan to buy shares and license tech.
There are allegations of fraud and misconduct by Henry Ji, the CEO of Scilex and Sorrento, with claims that he is hiding assets and defrauding investors.
The company's deals with Semnur and Scilex are considered extremely risky and may be attempts by Ji to manipulate the market.

Generated by AI

Sentiment

Of the messages about SCLX that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	0%	0% -83.33	83.87% +33.87	55.45% -6.2
Bearish	100%	100% +83.33	16.13% -33.87	44.55% +6.2

Bullish· Nov 21

$SCLX has the potential for a significant short squeeze due to the unique settlement requirements of the meme coin dividend, which may force short sellers to buy back shares and meme coins, leading to a potential price increase.
The company's recent move is driven by bullish analyst coverage, technical signals, and anticipation of the meme coin dividend, which may lead to a broad unwinding of short interest.
$SCLX has shown a strong price increase, with one investor selling shares at a profit of $332 after buying them at $20.65, indicating potential for continued growth.

Bearish· Jun 16

Scilex Holding Company ($SCLX) is expected to list its Dream Bowl Tokens on Biconomy Exchange, potentially diluting the value of existing shares.
The company's previous spin-offs have resulted in significant losses for main stock holders, with the new stock often trading at a lower price than expected.
Scilex Holding Company's financial situation is precarious, with the company potentially needing to sell a large number of shares to raise capital for a trial, which could further depress the stock price.

Generated by AI

Topics

Of the messages about SCLX that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	97.14%	26.52%
Earnings	—	—	0%	0.14%
Technical Analysis	—	—	0%	6.29%
Controversies	—	—	2.86%	5.35%
Analysts	—	—	0%	54.19%
Macro	—	—	0%	7.51%

Jul 6

Scilex Holding Company has signed a binding term sheet for a $100 million strategic investment from iHolding Group, with the investment expected to be used for growth initiatives, product development, and commercialization.
The investment will involve the purchase of approximately 6.67 million newly issued shares of Scilex common stock at $15.00 per share.
The deal is expected to provide a significant boost to Scilex's liquidity and confidence, and may have implications for the company's future growth and development.

Generated by AI

Community

Of the messages about SCLX, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	85%	72.15%	54.75%
Newcomers	0%	15%	27.85%	45.25%

Regulars· Apr 24

The debt holders of Scilex Holding Company ($SCLX) have filed an emergency motion to sell their shares via blocks to financial investors, potentially leading to a share price dump.
The stock price of Scilex Holding Company ($SCLX) has been impacted by a short sale restriction, with some users suggesting it could be a sign of a turnaround.
The stock price of Scilex Holding Company ($SCLX) has opened with a 5% gap down, with some users noting the potential for a reversal given the lack of available shares for short selling.

Newcomers· Aug 1

The newcomer is excited about Mass General's scanning of MS patients and believes it could lead to a significant increase in the stock price of SCLX.
The user is comparing SCLX to another stock, QNTM, suggesting that QNTM has not yet reached its full potential.
The newcomer is drawing parallels between GME and SCLX, implying that GME's success is a model for SCLX's future performance.

Generated by AI

News

Scilex Holding raises Vivasor credit line to $30 million in amended agreement

15h agoInvesting.com

Oramed Pharmaceuticals: Hold Reiterated As Alpha Tau Investment Delivers And More (ORMP)

18d agoSeeking Alpha

Federal Court Grants Motion to Stay Proceedings in Scilex v. Wade et al.

Newswire.ca Press Release.

1mo agoThe Globe and Mail

Scilex Establishes $20 Million Credit Facility for Vivasor

Detailed price information for Scilex Holding Co. (SCLX-Q) from The Globe and Mail including charting and trades.

1mo agoThe Globe and Mail

Scilex Holding establishes $20 million revolving credit line for Vivasor

1mo agoInvesting.com

Scilex Announces Strategic Sale of Vivasor Preferred Shares

Detailed price information for Scilex Holding Co. (SCLX-Q) from The Globe and Mail including charting and trades.

2mo agoThe Globe and Mail

Also Discussed

Investors talking about SCLX also mention

#	Name	Attention
1	Sorrento Therapeutics Inc.SRNE	0%0
2	DECA - Denali Capital Acquisition Corp.	——
3	Celularity Inc. Class A Common StockCELU	0%0
4	STAI - ScanTech AI Systems Inc.	——
5	Lyell Immunopharma, Inc.LYEL	0.01%new
6	Scinai Immunotherapeutics Ltd. American Depositary SharesSCNI	0%new
7	ImmunityBio Inc.IBRX	0.28%-0.06
8	Oramed Pharmaceuticals Inc.ORMP	0%new
9	Surgery Partners Inc.SGRY	0%0
10	Celcuity Inc.CELC	0%0

Scilex Holding Co.

Healthcare
Drug Manufacturers - General

Scilex Holding Co. is a commercial biopharmaceutical company focused on developing and marketing non-opioid pain management products for acute and chronic pain. Its current portfolio includes ZTlido, a topical lidocaine patch used for neuropathic pain linked to postherpetic neuralgia, ELYXYB, an oral solution for the acute treatment of migraine in adults, and GLOPERBA, a liquid oral colchicine product for gout flare prophylaxis. The company operates in the healthcare and pharmaceuticals market, serving the need for alternatives to opioid-based therapies through prescription products designed for targeted pain conditions. Scilex Holding Co. also works across product acquisition, development, and commercialization, giving it a role in both specialty pain treatment and broader pharmaceutical distribution. Based in Palo Alto, California, the company is positioned within the non-opioid pain management segment of the biopharmaceutical industry.

Website

Location

960 San Antonio Road

Palo Alto, CA, 94303

United States

Social

What share of all stock conversation is about SCLX?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Attention	0% new	0% +0	0% +0	0% 0

Jul 8

Scilex Holding Company ($SCLX) is involved in a joint venture that will send 500k shares to Quantum Scan to buy shares and license tech.
There are allegations of fraud and misconduct by Henry Ji, the CEO of Scilex and Sorrento, with claims that he is hiding assets and defrauding investors.
The company's deals with Semnur and Scilex are considered extremely risky and may be attempts by Ji to manipulate the market.

Generated by AI

Sentiment

Of the messages about SCLX that take a side, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Bullish	0%	0% -83.33	83.87% +33.87	55.45% -6.2
Bearish	100%	100% +83.33	16.13% -33.87	44.55% +6.2

Bullish· Nov 21

$SCLX has the potential for a significant short squeeze due to the unique settlement requirements of the meme coin dividend, which may force short sellers to buy back shares and meme coins, leading to a potential price increase.
The company's recent move is driven by bullish analyst coverage, technical signals, and anticipation of the meme coin dividend, which may lead to a broad unwinding of short interest.
$SCLX has shown a strong price increase, with one investor selling shares at a profit of $332 after buying them at $20.65, indicating potential for continued growth.

Bearish· Jun 16

Scilex Holding Company ($SCLX) is expected to list its Dream Bowl Tokens on Biconomy Exchange, potentially diluting the value of existing shares.
The company's previous spin-offs have resulted in significant losses for main stock holders, with the new stock often trading at a lower price than expected.
Scilex Holding Company's financial situation is precarious, with the company potentially needing to sell a large number of shares to raise capital for a trial, which could further depress the stock price.

Generated by AI

Topics

Of the messages about SCLX that carry a topic, what share is each?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y
Announcements	—	—	97.14%	26.52%
Earnings	—	—	0%	0.14%
Technical Analysis	—	—	0%	6.29%
Controversies	—	—	2.86%	5.35%
Analysts	—	—	0%	54.19%
Macro	—	—	0%	7.51%

Jul 6

Scilex Holding Company has signed a binding term sheet for a $100 million strategic investment from iHolding Group, with the investment expected to be used for growth initiatives, product development, and commercialization.
The investment will involve the purchase of approximately 6.67 million newly issued shares of Scilex common stock at $15.00 per share.
The deal is expected to provide a significant boost to Scilex's liquidity and confidence, and may have implications for the company's future growth and development.

Generated by AI

Community

Of the messages about SCLX, what share comes from each group?

	1 Day1D	1 Week1W	1 Month1M	1 Year1Y	50-Day MAclick to plot	200-Day MAclick to plot
Regulars	100%	85%	72.15%	54.75%
Newcomers	0%	15%	27.85%	45.25%

Regulars· Apr 24

The debt holders of Scilex Holding Company ($SCLX) have filed an emergency motion to sell their shares via blocks to financial investors, potentially leading to a share price dump.
The stock price of Scilex Holding Company ($SCLX) has been impacted by a short sale restriction, with some users suggesting it could be a sign of a turnaround.
The stock price of Scilex Holding Company ($SCLX) has opened with a 5% gap down, with some users noting the potential for a reversal given the lack of available shares for short selling.

Newcomers· Aug 1

The newcomer is excited about Mass General's scanning of MS patients and believes it could lead to a significant increase in the stock price of SCLX.
The user is comparing SCLX to another stock, QNTM, suggesting that QNTM has not yet reached its full potential.
The newcomer is drawing parallels between GME and SCLX, implying that GME's success is a model for SCLX's future performance.

Generated by AI

Scilex Holding

Social

Jul 8

Bullish· Nov 21

Bearish· Jun 16

Jul 6

Regulars· Apr 24

Newcomers· Aug 1

Scilex Holding raises Vivasor credit line to $30 million in amended agreement

Oramed Pharmaceuticals: Hold Reiterated As Alpha Tau Investment Delivers And More (ORMP)

Federal Court Grants Motion to Stay Proceedings in Scilex v. Wade et al.

Scilex Establishes $20 Million Credit Facility for Vivasor

Scilex Holding establishes $20 million revolving credit line for Vivasor

Scilex Announces Strategic Sale of Vivasor Preferred Shares

Also Discussed

Scilex Holding Co.

Company Information

Location

Scilex Holding raises Vivasor credit line to $30 million in amended agreement

Oramed Pharmaceuticals: Hold Reiterated As Alpha Tau Investment Delivers And More (ORMP)

Federal Court Grants Motion to Stay Proceedings in Scilex v. Wade et al.

Scilex Establishes $20 Million Credit Facility for Vivasor

Scilex Holding establishes $20 million revolving credit line for Vivasor

Scilex Announces Strategic Sale of Vivasor Preferred Shares

Also Discussed

Social

Jul 8

Bullish· Nov 21

Bearish· Jun 16

Jul 6

Regulars· Apr 24

Newcomers· Aug 1